Cipher Mining Inc vs Danaher Corporation — how do they compare? Cipher Mining Inc trades at $17.73 (market cap $7.14B), while Danaher Corporation trades at $206.47 (market cap $145.83B). The key difference: Danaher Corporation is far larger — about 20.4× Cipher Mining Inc's market cap, and Danaher Corporation pays a 0.77% dividend while Cipher Mining Inc pays none. Which is the better fit depends on your goals.
| CIFR | DHR | |
|---|---|---|
Market Cap | $7.14B | $145.83B |
Sector | Basic Materials | Health |
52-Week High | $29.18 | $242.05 |
52-Week Low | $4.72 | $161.91 |
Enterprise Value | $11.90B | $168.04B |
Dividend Yield | — | 0.77% |
Signals from Pluang's Aura AI — not financial advice
CIFR trades at $18.35, up 12.37% in the last 24 hours, but remains in a bearish technical trend. The company reported a Q2 2026 loss of $0.65 per share, missing estimates, with revenue declining and net losses widening. Despite negative profitability metrics, analyst consensus is unanimously bullish with a $31.78 price target, citing progress in its transition to AI data center operations and accelerated project deliveries.
The outlook hinges on successful execution of its AI infrastructure pivot, offering significant upside if targets are met, but high execution risks and persistent losses pose substantial threats to shareholder value. Investors face volatility amid the business model transition.
Danaher (DHR) trades at $209.26, up 2.2% today, with strong technical momentum as the price sits above key support levels. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.92. Fundamentals show robust profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst sentiment is overwhelmingly positive with 69% buy ratings and a $202.33 consensus price target. Recent news highlights the acquisition of Masimo and new product launches in its biotechnology segment.
The outlook for DHR remains favorable driven by earnings beats and strategic acquisitions, but investors face risks from elevated valuation multiples and potential macroeconomic headwinds. The stock's current technical overbought condition suggests near-term consolidation may occur, yet long-term growth prospects in life sciences support a bullish stance. Key watch points include Q3 2026 earnings results and integration progress of recent acquisitions.
Trailing returns across standard periods
Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.
Read more on CIFR →In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →